After review, the U$.$S$.$ Food and Drug

Administration $($FDA$)$ recently rejected

a new drug offered by a

pharmaceutical company. Industry

analysts are now predicting that the

company's earnings will fall in the

next two financial quarters and the

company's share price has fallen

dramatically. What type of risk has

caused the stock's price to fall?

A Legislative risk

B Event risk

C Business risk

Regulatory risk